Abstract
The subject of mixed glial neoplasms has continued to be a source of considerable debate. Most people recognize that a glial neoplasm may show phenotypic features of more than one glioma type, most commonly a mixture of astrocytoma and oligodendroglioma (oligoastrocytoma). The major question arises, however, as to exactly what point one crosses the threshold in designating the lesion as mixed as opposed to calling it a pure glioma. Unfortunately, the literature has not been terribly helpful in this arena; many of the articles that have dealt with the subject have not specifically defined what is meant by a mixed glioma and those that do, do so somewhat arbitrarily, resulting in a lack of uniformity or agreement. Precise guidelines as to what percentage of a second glial component one needs to see in order to designate a tumor as “mixed” remains unclear. In the single largest series of mixed gliomas published to date, written over twenty years ago, mixed gliomas were simply defined as tumors of the brain and spinal cord comprised of two or more neoplastic counterparts of the normal glial cellular constituents of the central nervous system, without further specification with regard to how much of a second component one needed to see in order to designate the lesion as “mixed glioma” (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hart, M.N., Petito, C.K., Earle, K.M. (1974) Mixed gliomas. Cancer 33: 134–140.
Kleihues, P., Burger, P.C., Scheithauer, B.W. (1993) In: Histologic Typing of Tumours of the Central Nervous System. 2nd Ed. New York: Springer-Verlag.
Burger, P.C., Scheithauer, B.W. (1994) Tumors of neuroglial and choroid plexus epithelium. In: Tumors of the Central Nervous System. Washington D.C. Armed Forces Institute of Pathology, 3nd series. pp 25–161.
Mt rk, S.J., Halvorsen, T.B., Lindegard, K-F., Eide, G.E. (1986) Oligodendroglioma: histologic evaluation and prognosis. J. Neuropathol. Exp. Neurol. 45: 65–78.
Burger, P.C., Rawlings, C.E., Cox, E.B., McLendon, R.E., Schold, Jr. S.C., Bullard, D.E. (1987) Clinicopathologic correlations in the oligodendroglioma. Cancer 59: 1345–1352.
Bello, M.J., Leone, P.E., Vaquero, J., deCampos, J.M., Kusak, M.E., Sarasa, J.L., Pestana, A., Rey, J.A. (1995). Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int. J. Cancer 64: 207–210.
Beckmann, M.J., Prayson, R.A. (1997) A clinicopathologic study of 30 cases of oligoastrocytoma including p53 immunohistochemistry. Pathology 29: 159–164.
de la Monte, S.M. (1989) Uniform lineage of oligodendrogliomas. Am. J. Pathol. 135: 529–540.
Raff, M.C., Miller, R.H. (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303: 390–396.
Kennedy, P.G., Fok-Seang, J. (1986) Studies on the development, antigenic phenotype and function of human glial cells in tissue culture. Brain 109: 1261–1277.
Min, K.W., Scheithauer, B.W. (1994) Oligodendroglioma: the ultrastructural spectrum. Ultrastruct. Pathol. 18: 47–60.
Jaskólsky, D., Zawirski, M., Papierz, W., Kotwica, Z. (1987) Mixed gliomas: their clinical course and results of surgery. Zentralbl. Neurochir. 48: 120–123.
Shaw, E.G., Scheithauer, B.W., O’Fallon, J.R., Davis, D.H. (1994) Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 34: 577–582.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Prayson, R.A., Cohen, M.L. (2000). Mixed Gliomas. In: Practical Differential Diagnosis in Surgical Neuropathology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-037-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-037-7_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-201-8
Online ISBN: 978-1-59259-037-7
eBook Packages: Springer Book Archive